News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Civitas Announces Positive Results from Phase II Inhaled Levodopa Trial


Civitas Therapeutics announced that its inhaled formulation of levodopa (L-dopa) for the treatment of "off episodes" associated with Parkinson's disease met its primary clinical endpoint in a Phase II trial. Read more…